2025 Nov 11 at 10:31
in Pain-Free Living Off The Grid
*** begin quote ***
The Quiet Rise of a Pharmaceutical Star
It didn’t start out this way. Back in the ’90s, gabapentin was just another seizure med. Then came the sales push. The company behind it sent reps and doctors to fancy dinners and “educational retreats,” where talk quietly turned to off-label uses—headaches, mood swings, ADHD, you name it. Eventually, that little scheme cost them almost half a billion in fines. You’d think that would’ve ended the story.
But then the opioid crisis hit. When OxyContin started wrecking lives and headlines screamed addiction and death, doctors needed something—anything—that wouldn’t destroy their patients or careers.
Gabapentin looked like a safe harbor: cheap, not technically addictive, and tolerated well enough. So, when the pain didn’t fit a neat category, gabapentin became the fallback.
*** end quote ***
Posted by reinkefj 







